Back to top

Supernus Investors Approve Directors, Pay and Incentive Plan

Supernus Pharmaceuticals ( ($SUPN) ) has issued an announcement. On June 18, 2026, Supernus Pharmaceuticals held its annual meeting of stockholders...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Supernus Pharmaceuticals, Inc. (SUPN)